Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by a selective loss of dopaminergic neurons in the substantia nigra (SN). It has been suggested that microglial inflammation augments the progression of PD. Neuromelanin (NM), a complex polymer pigment found in catecholaminergic neurons, has sparked interest because of the suggestion that NM is involved in cell death in Parkinson's disease, possibly via microglia activation. To further investigate the possible role of NM in the pathogenesis of PD, we conducted in vivo experiments to find out whether microglial cells become activated after injection of human neuromelanin (NM) into (1) the cerebral cortex or (2) the substantia nigra to monitor in this PD-relevant model both microglial activation and possible neurodegeneration. In this study, adult male Wistar rats received an intracerebral injection of either NM, bacterial lipopolysaccharide (LPS, positive control), phosphate-buffered saline (PBS, negative control) or colloidal gold suspension (negative particular control). After different survival times (1, 8 or 12 weeks), brain slices from the cerebral cortex or substantia nigra (SN, 1 week) were stained with Iba-1 and/or GFAP antibody to monitor microglial and astrocytic reaction, and with tyrosine hydroxylase (TH) to monitor dopaminergic cell survival (SN group only). The injection of LPS induced a strong inflammatory response in the cortex as well in the substantia nigra. Similar results could be…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The archetype, riboflavin, acquires a dioxetane when illuminated, due to cycloaddition of 1O2* produced by excited riboflavin (115).”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [115]
In the citing paper
“FAD and FMN (flavin adenine dinucleotide and flavin mononucleotide) have electron transfer as their function (115), particularly in the mitochondria.”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [115]
In the citing paper
“In-vitro and in-vivo studies have confirmed the ability of neuromelanin to activate microglia and induce death of dopamine neurons.127,128”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [127]
In the citing paper
“In addition, the neuromelanin (dark, complex endogenous polymer derived from DA) can activate microglial cells, inducing neuroinflammation and neurodegeneration of dopaminergic neurons in PD (Zecca et al., 2008; Herrera et al., 2015).”
From The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma. (2017) · cites this paper as Zecca et al., 2008
In the citing paper
“Dopamine-derived quinones (DA-Q) can undergo intramolecular cyclization and oxidation to form leukochrome, aminochrome, and finally, neuromelanin, a pigment involved in neuroinflammation and neurodegeneration (Zecca et al. 2008).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Zecca et al. 2008
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045 · cited 5×
“Like other tissue macrophages in the Wrst line of host defence, microglia play a pivotal role as phagocytic, antigen-presenting cells acting in concert with invading immune cells to defend the immunological integrity of the CNS.”
InfluentialMicroglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557 · cited 1×
“, proteolytic enzymes, reactive oxygen intermediates (ROIs) or NO), and damage CNS cells [2, 4, 11, 21, 30].”
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · cited 1×
“... protective functions, by, for example, supplying glial-derived neurotrophic factor (GDNF), interferons and tumor necrosis factor (TNF-), they may participate in an ongoing cell death following the initial toxic insult by releasing various kinds of noxious factors such as cytokines (i.e., TNF-, IL-1, IL-6) or proin…”
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · cited 1×
“, proteolytic enzymes, reactive oxygen intermediates (ROIs) or NO), and damage CNS cells [2, 4, 11, 21, 30].”
Banati, R. B., Gehrmann, J., Schubert, P., & Kreutzberg, G. W. (1993) · Glia · doi:10.1002/glia.440070117 · Cited by 1,029
Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791 · cited 2×
“In parkinsonian brains, also the regions receiving projections from substantia nigra like putamen have areas with microglial activation, which is secondary to the degeneration of the neuronal processes [14].”
Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403495101 · Cited by 495
Self-citation
Cited by
Items 201–230 of 230
Parkinson’s Disease: Neurochemistry and Pharmacological Treatment
Bisht, S., Singh, M. F., & Upaganlawar, A. B. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_6
Удовицький, В. В., & Бессарабов, В. І. (2026) · Farmatsevtychnyi zhurnal · doi:10.32352/0367-3057.2.26.07
Nikolenko, V. N., Rizaeva, N. A., Oganesyan, M. V., Zubkova, M., Golyshkina, M. S., Orluk, M. A., Pelicer, Y. C., Sabekia, R., Morozow, A., Pires, L. A. S., et al. (2026) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-026-00330-8
Brain immune response as therapeutic target in the treatment of parkinson's disease
Rabaneda‐Lombarte, N. (2019) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Treating neuroinflammation: Exploring its potential in Parkinson's disease
Ahmed-Landeryou, M. J. (2009) · British Journal of Neuroscience Nursing · doi:10.12968/bjnn.2009.5.11.45147
Wallstein, N., Capucciati, A., Pöppl, A., Schnohr, C. S., Sturini, M., Pampel, A., Jäger, C., Zecca, L., Zucca, F. A., Monzani, E., et al. (2025) · Angewandte Chemie · doi:10.1002/ange.202509102
Self-citationThe use of human astrocytes in studies of Parkinson’s disease pathology
Tasneem, K. (2020) · UEF eRepo (University of Eastern Finland)
Glial glucocorticoid geceptors in parkinsonism
Maatouk, L. (2015) · theses.fr (ABES) · doi:10.70675/1256b391z3e4fz471bz8360ze0eee3d095a8
Exploring Neuropathology in delta122p53 Mouse Models
Naik, N. (2021) · Otago University Research Archive (University of Otago)
Neurotoxicidade do ferro na fisiopatologia da doença de Parkinson
Calou, I. B. F., Cerqueira, G. D. S., & Siqueira, R. M. P. (2015) · Revista Intertox de Toxicologia Risco Ambiental e Sociedade · doi:10.22280/revintervol8ed1.193
Kliiniset tutkimukset ulosteensiirtohoidon vaikutuksista Parkinsonin taudissa
Leskinen, T. (2024) · UTUPub (University of Turku)
Механизмы нейродегенерации при болезни Паркинсона. Активация микроглии
Kucheryanu, V. G., Бочаров, Е. В., Kryzhanovskiy, G. N., Bocharova, O. A., & Poleshchuk, V. V. (2023) · Nauchno-prakticheskii zhurnal «Patogenez»
Behrendt, P. (2014) · MACAU: Open Access Repository of Kiel University
Vanna, R. (2012) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/vanna-renzo_phd2012-02-08
Genes envolvidos na determinação de Parkinson
Teixeira, D. D. C. E. C. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Claasen, J.-H. (2010) · MACAU: Open Access Repository of Kiel University
Self-citationEinfluss von Kavalaktonen auf Mikroglia und Astrozyten
Neumann, J. (2015) · MACAU: Open Access Repository of Kiel University
Oberländer, U. (2012) · Online Publication Service of Würzburg University (Würzburg University)
Álvarez, P. F. (2020) · Repositorio institucional da Universidade de Santiago de Compostela (University of Santiago de Compostela)
Green, E. L. (2021) · Keele Research Repository (Keele University)
Decoding Oxidative Stress: Novel Mechanistic Pathways in Neurodegeneration
Yadav, P., Kumar, D., Anil Kumar, M. S., & Kumar, U. (2026) · Current Neuroscience · doi:10.2174/0129505623441229260714100114
Optimizing Parkinson’s disease Diagnosis: A Clinical Review Magnetic Resonance Imaging (MRI)
Krustesen, J. (2018) · Neuroscience and Neurological Surgery · doi:10.31579/2578-8868/031
Narducci, R. (2014) · Florence Research (University of Florence)
Mecanismos de neurotoxicidade induzida pela administração de LPS e paraquat
Gonçalves, C. L. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Re: Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury
Jin, Z.-F. (2012) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e318268345b
Metadata
- Authors
- Zecca, L., Wilms, H., Geick, S., Claasen, J.-H., Brandenburg, L.-O., Holzknecht, C., Panizza, M. L., Zucca, F. A., Deuschl, G., Sievers, J., & Lucius, R.
- Affiliations
- Institute of Biomedical Technologies (IT)
- Heidelberg University (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- Corresponding author
- Lucius, Ralph
- Venue
- Acta Neuropathologica
- Published
- 2008-03-15
- Volume
- 116
- Issue
- 1
- Pages
- 47-55
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W1979975559
- Cited by
- 205
- References
- 37
- Citations by year
- 2026: 4 · 2025: 16 · 2024: 9 · 2023: 17 · 2022: 14 · 2021: 17 · 2020: 10 · 2019: 12 · 2018: 4 · 2017: 8 · 2016: 9 · 2015: 13 · 2014: 11 · 2013: 12 · 2012: 15
- FWCI
- 7.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- neuromelanin, Parkinson's disease, substantia nigra, microglial activation, neuroinflammation, neurodegeneration, dopaminergic neuron loss, catecholaminergic neurons, astrocyte activation, lipopolysaccharide, intracerebral injection, Iba1, tyrosine hydroxylase
- MeSH terms
- Animals, Humans, Immunohistochemistry, Inflammation, Male, Melanins, Nerve Degeneration, Neurons, Substantia Nigra, Tyrosine 3-Monooxygenase, Cell Death, Rats, Wistar, Microglia, Parkinsonian Disorders, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.